What is Cytokinetics's revenue?

Cytokinetics (CYTK) generated $105.8M in revenue over the trailing twelve months, up 450.6% year over year.

Is Cytokinetics profitable?

Cytokinetics is not currently profitable: it reported a net loss of $829.6M over the trailing twelve months, a -784.0% net margin.

What is Cytokinetics's earnings per share?

Cytokinetics's diluted EPS over the trailing twelve months is $-6.84.

Where does Cytokinetics's income statement data come from?

Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Cytokinetics CYTK Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$105.82M+451%	$88.04M+377%	$87.21M+2,609%	$85.74M+2,636%	$19.22M+412%
Research and development	$411.71M+15.6%	$414.45M+22.1%	$403.68M+22.0%	$389.06M+18.4%	$356.1M+7.2%
Selling, general and administrative	——	——	——	——	——
General and administrative	——	$284.27M+32.0%	$254.89M+29.3%	$242.08M+34.1%	$227.18M+34.1%
Total operating expenses	$746.06M+27.6%	$700.3M+26.2%	$660.14M+25.1%	$632.72M+24.3%	$584.86M+16.6%
Operating income	-$640.25M-13.2%	-$612.26M-14.2%	-$572.93M-9.2%	-$546.98M-8.1%	-$565.64M-13.6%
Operating margin	-605.1%+2,338pp	-695.4%+2,207pp	-656.9%+15,641pp	-638%+15,510pp	-2,943.3%+10,329pp
Interest expense	$51.23M+29.8%	$45.58M+20.9%	$40.24M+12.0%	$37.82M+10.8%	$39.47M+38.7%
Other income (expense), net	$45.74M-20.2%	$48.42M-6.0%	$51.96M+17.8%	$58.77M+73.4%	$57.32M+96.9%
Net income	-$829.61M-34.8%	-$784.96M-33.2%	-$751.94M-30.5%	-$606.31M-11.2%	-$615.26M-16.0%
Net margin	-784%+2,417pp	-891.6%+2,300pp	-862.2%+17,044pp	-707.2%+16,692pp	-3,201.5%+10,940pp
Diluted earnings per share	-$6.84-29.3%	-$6.53-24.1%	-$6.29-16.9%	-$5.10+5.0%	-$5.29+2.0%
EBITDA	-$629.04M-13.1%	-$602.13M-14.3%	-$563.29M-10.2%	-$537.6M-9.0%	-$556.14M-14.5%
EBITDA margin	-594.5%+2,299pp	-683.9%+2,167pp	-645.9%+15,233pp	-627%+15,109pp	-2,893.9%+10,048pp
EBIT	-$640.25M-13.2%	-$612.26M-14.2%	-$572.93M-9.2%	-$546.98M-8.1%	-$565.64M-13.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Cytokinetics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytokinetics's revenue?: Cytokinetics (CYTK) generated $105.8M in revenue over the trailing twelve months, up 450.6% year over year.
Is Cytokinetics profitable?: Cytokinetics is not currently profitable: it reported a net loss of $829.6M over the trailing twelve months, a -784.0% net margin.
What is Cytokinetics's earnings per share?: Cytokinetics's diluted EPS over the trailing twelve months is $-6.84.
Where does Cytokinetics's income statement data come from?: Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.